SCHEMBL23327012

SCHEMBL23327012

CCOC(=O)c1cc2c(Oc3ccc4c(c3)CN(C(=O)O)CC4)c(F)cnc2[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 9/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HRH3 Q9Y5N1 2/20 0.35
▸ F2 P00734 2/20 0.35
▸ PLG P00747 2/20 0.35
▸ PRSS1 P07477 2/20 0.35
▸ PRSS2 P07478 2/20 0.35
▸ PRSS3 P35030 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SPR P35270 1/20 0.34
▸ CYP4F2 P78329 1/20 0.34
▸ CYP4A11 Q02928 1/20 0.34
▸ CCNT1 O60563 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21470821 0.90 NR1H2 (0.44) F10MAPTESR2CCNT1CDK9
SCHEMBL23326985 0.80 KIT (0.42) —
SCHEMBL23327006 0.76 F10 (0.39) F10F2PLGPRSS1PRSS2
SCHEMBL21470820 0.75 NR1H2 (0.42) HRH3MAPTESR2CCNT1CDK9
SCHEMBL23326982 0.73 ROCK2 (0.32) HRH3CHRM4CYP4F2CYP4A11
SCHEMBL21470706 0.71 NR1H2 (0.42) MAPTESR2CCNT1CDK9
SCHEMBL21470708 0.68 KIT (0.42) —
SCHEMBL23326727 0.68 HAO1 (0.38) F10HRH3PLGPRSS1PRSS2
SCHEMBL5137232 0.67 HRH3 (0.58) F10KMT2AHRH3HPGD
SCHEMBL21470507 0.67 NR1H2 (0.47) F10F2PLGPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139484-A1 DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS GOSSAMER BIO SERVICES INC (US) 2021-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139484-A1 DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS ULK1, PHKG2, PHKG1 F10 4793/4885MEN1 2519/4885KMT2A 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback